loading, an associated increase in apoplastic (cell wall) Ca 2C concentration and reduced gas exchange, growth and fitness.
15, 16 The existence of analogous CAXs have been proposed in animals based on early biochemical work in sea urchin eggs. 17 This study showed blockade of Ca 2C uptake into target NAADP-sensitive stores by agents that collapsed proton gradients such as bafilomycin A1(a V-type H C ATPase inhibitor), but not by vanadate (a P-type Ca 2C ATPase inhibitor) 17 consistent with secondary active transport of Ca 2C . Indeed, such a proposal has received widespread support where Ca 2C release by NAADP or NAADP-forming agonists is consistently blocked by bafilomycin A1 across a multitude of cells. [18] [19] [20] However, the molecular identity of animal CAXs has been somewhat of a mystery.
Recent work identified several putative animal CAXs through searches of the ever-increasing genomic sequences now at our disposal. 21 These genes were found in protostomes such as gastropods and polychaetes, and deuterostomes from basal animal species (reassuringly including the sea urchin, an echinoderm) through to amphibians and non-placental mammals. CAXs were cloned from the purple sea urchin and the African clawed frog. The latter was heterologously expressed in yeast where it was shown to possess Ca 2C -H C activity In both frog 21 and zebrafish 23 embryos, transcripts for endogenous CAX were enriched in the neural crest. Within these highly migratory embryonic cells, CAX localized to yolk granules and small acidic vesicles (likely lysosomes). 21 The former finding is interesting as it was these very same lysosome-like organelles that were originally identified as NAADP-sensitive Ca 2C stores in sea urchin eggs. 17 Live cell imaging indicated that the smaller CAX-positive vesicles were highly mobile, often populating the leading edge of migrating neural crest cells. 21 Indeed, knockdown of CAX disrupted multiple cell migration processes in neural crest explants including focal adhesion formation, cell spreading and chemotaxis. Importantly, migration of the neural crest was also disrupted in vivo. Thus, this study 21 (Fig. 1) . But what about Ca 2C uptake into acidic Ca 2C stores in human cells given the apparent lack of CAX homologues in placental mammals? It is formally possible (although in my opinion unlikely) that CAXs within our lineage have substantially diverged in sequence to make them invisible to current homology searches. Alternatively, Ca 2C uptake could be mediated through a novel protein with Ca 2C -H C exchange activity, 24 or even through combinations of proteins (eg coupled Na C /H C and Na C /Ca 2C exchange). 25 A recent study has suggested that lysosomal Ca 2C filling is achieved by neighboring IP 3 -sensitive Ca 2C release channels on the ER but via a route that does not require a proton gradient. 26 Certainly, identified membrane contact sites between the ER and lysosomes would facilitate this 27 ,28 similar to their proposed role in amplifying lysosomal Ca 2C signals by the ER. 29 But the reported insensitivity of lysosomal Ca 2C uptake to bafilomycin A1 (assessed by monitoring Ca 2C signals evoked by the TRP mucolipin activator MLSA1), 26 is difficult to reconcile with previous studies; the findings are at odds not only with the aforementioned bafilomycin A1-sensitivity of NAADP action but also work by the same authors 30 and others 31 showing inhibition of MLSA1-evoked Ca 2C signals upon V-type H C ATPase blockade. Clearly further work is required to clarify the mechanisms mediating lysosomal Ca 2C uptake in mammalian cells, the importance of which is underscored by functional evidence linking signaling through acidic Ca 2C stores to cell migration.
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